The latest update is out from Livzon Pharmaceutical Group ( (HK:1513) ).
Livzon Pharmaceutical Group has clarified details regarding its capital contribution to LivzonBio, correcting previous statements about the nature of the shares and equity interest involved. The clarification indicates that the company subscribed for increased registered capital, securing an 18.85% equity interest in LivzonBio, which may impact its financial positioning and stakeholder interests.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development and production of medical products and services.
YTD Price Performance: 1.16%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.08B
Learn more about 1513 stock on TipRanks’ Stock Analysis page.